166 related articles for article (PubMed ID: 22967811)
1. Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.
Cheng XC; Wang RL; Dong ZK; Li J; Li YY; Li RR
Bioorg Med Chem; 2012 Oct; 20(19):5738-44. PubMed ID: 22967811
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of derivatives of methyl rosmarinate and their inhibitory activities against matrix metalloproteinase-1 (MMP-1).
Yuan H; Lu W; Wang L; Shan L; Li H; Huang J; Sun Q; Zhang W
Eur J Med Chem; 2013 Apr; 62():148-57. PubMed ID: 23353736
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of tyrosine-based hydroxamic acid analogs as novel histone deacetylases (HDACs) inhibitors.
Zhang Y; Feng J; Liu C; Fang H; Xu W
Bioorg Med Chem; 2011 Aug; 19(15):4437-44. PubMed ID: 21733698
[TBL] [Abstract][Full Text] [Related]
4. Is dual inhibition of metalloenzymes HDAC-8 and MMP-2 a potential pharmacological target to combat hematological malignancies?
Amin SA; Adhikari N; Jha T
Pharmacol Res; 2017 Aug; 122():8-19. PubMed ID: 28501516
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and preliminary evaluation of α-sulfonyl γ-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.
Zhang J; Li X; Jiang Y; Feng J; Li X; Zhang Y; Xu W
Bioorg Med Chem; 2014 Jun; 22(11):3055-64. PubMed ID: 24755524
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
Cheng XC; Wang Q; Fang H; Tang W; Xu WF
Bioorg Med Chem; 2008 May; 16(10):5398-404. PubMed ID: 18440232
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.
Cheng XC; Wang Q; Fang H; Tang W; Xu WF
Eur J Med Chem; 2008 Oct; 43(10):2130-9. PubMed ID: 18362041
[TBL] [Abstract][Full Text] [Related]
8. Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.
Yan XQ; Wang ZC; Li Z; Wang PF; Qiu HY; Chen LW; Lu XY; Lv PC; Zhu HL
Bioorg Med Chem Lett; 2015 Oct; 25(20):4664-71. PubMed ID: 26346367
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and preliminary bioactivity studies of 1,3,4-thiadiazole hydroxamic acid derivatives as novel histone deacetylase inhibitors.
Guan P; Sun F; Hou X; Wang F; Yi F; Xu W; Fang H
Bioorg Med Chem; 2012 Jun; 20(12):3865-72. PubMed ID: 22579621
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological activity of boronic acid-based histone deacetylase inhibitors.
Suzuki N; Suzuki T; Ota Y; Nakano T; Kurihara M; Okuda H; Yamori T; Tsumoto H; Nakagawa H; Miyata N
J Med Chem; 2009 May; 52(9):2909-22. PubMed ID: 19419205
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors.
Wang Q; Chen M; Zhu H; Zhang J; Fang H; Wang B; Xu W
Bioorg Med Chem; 2008 May; 16(10):5473-81. PubMed ID: 18467109
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of MMP inhibitors with appended fluorescent tags for imaging and visualization of matrix metalloproteinase enzymes.
Freskos JN; Asmelash B; Gaston KR; Karwa A; Marzan TA; Nickols MA; Rogers TE; Schoenstein T; Sympson CJ; Vu B
Bioorg Med Chem Lett; 2013 Oct; 23(20):5566-70. PubMed ID: 23999043
[TBL] [Abstract][Full Text] [Related]
13. Progress towards water-soluble triazole-based selective MMP-2 inhibitors.
Fabre B; Filipiak K; Zapico JM; Díaz N; Carbajo RJ; Schott AK; Martínez-Alcázar MP; Suárez D; Pineda-Lucena A; Ramos A; de Pascual-Teresa B
Org Biomol Chem; 2013 Oct; 11(38):6623-41. PubMed ID: 23989288
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
Cheng XC; Wang Q; Fang H; Tang W; Xu WF
Bioorg Med Chem; 2008 Sep; 16(17):7932-8. PubMed ID: 18718763
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and primary activity assay of tripeptidomimetics as histone deacetylase inhibitors with linear linker and branched cap group.
Zhang Y; Feng J; Jia Y; Xu Y; Liu C; Fang H; Xu W
Eur J Med Chem; 2011 Nov; 46(11):5387-97. PubMed ID: 21924799
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, experimental evaluation and molecular modelling of hydroxamate derivatives as zinc metalloproteinase inhibitors.
Sjøli S; Nuti E; Camodeca C; Bilto I; Rossello A; Winberg JO; Sylte I; Adekoya OA
Eur J Med Chem; 2016 Jan; 108():141-153. PubMed ID: 26638045
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and preliminary activity assay of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as novel Histone deacetylases (HDACs) inhibitors.
Zhang Y; Feng J; Liu C; Zhang L; Jiao J; Fang H; Su L; Zhang X; Zhang J; Li M; Wang B; Xu W
Bioorg Med Chem; 2010 Mar; 18(5):1761-72. PubMed ID: 20171895
[TBL] [Abstract][Full Text] [Related]
18. Design and evaluation of 'Linkerless' hydroxamic acids as selective HDAC8 inhibitors.
Krennhrubec K; Marshall BL; Hedglin M; Verdin E; Ulrich SM
Bioorg Med Chem Lett; 2007 May; 17(10):2874-8. PubMed ID: 17346959
[TBL] [Abstract][Full Text] [Related]
19. Benzothiazole-containing hydroxamic acids as histone deacetylase inhibitors and antitumor agents.
Oanh DT; Hai HV; Park SH; Kim HJ; Han BW; Kim HS; Hong JT; Han SB; Hue VT; Nam NH
Bioorg Med Chem Lett; 2011 Dec; 21(24):7509-12. PubMed ID: 22036991
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.
Mou J; Fang H; Liu Y; Shang L; Wang Q; Zhang L; Xu W
Bioorg Med Chem; 2010 Jan; 18(2):887-95. PubMed ID: 19969464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
